GELS

Gelteq Limited

0.9000

+0.0068+0.76%

After Hours: 0.8498 -0.0502 -5.58%19:59 09/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.6600/0.6762

TODAY RANGE0.6356-0.8500

VOL700.23K

MARKET CAP9.10M

52 WEEK RANGE0.3870-2.010

AVG VOL (3M)6.00M

% TURNOVER6.24%

TURNOVER--

P/E (TTM)-3.5375

% RANGE31.71%

EPS(TTM)-0.2402

P/E(FORWARD)--

P/B1.003

BVPS0.8474

DIVIDEND--

P/S83.30

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.78M

SHARES OUTSTANDING10.71M

NEXT EARNINGS11/16-11/20

FREE FLOAT5.62M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·06/30 21:53
Gelteq Limited Advances Clinical Programs and Asia Expansion in First Half of 2026
NASDAQ·06/12 03:54
Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...
TipRanks·06/02 20:28
Gelteq Calls June 19 Special Meeting to Approve Potentially Dilutive Convertible Note Share Issuance
TipRanks·05/26 20:29
Gelteq Limited Secures Up to $3.5 Million in Convertible Debt Financing
Seeking Alpha·05/12 14:37
Gelteq secures up to $3.5M debt financing to support commercialization
TipRanks·03/24 12:49
Gelteq Warned by Nasdaq Over Minimum Bid Price Compliance
TipRanks·02/11 13:56
Gelteq, Healthy Extracts enter MOU for manufacturing, commercial partnership
TipRanks·01/13 14:16
Gelteq announces preclinical results on medicinal cannabinoid absorption
TipRanks·12/09/2025 20:47
Gelteq Limited Unveils Innovative Drug Delivery Platform in Investor Summit
TipRanks·12/09/2025 14:20
Gelteq entered into three year sales agreement with Mana Health
TipRanks·12/05/2025 15:45
Gelteq announces preclinical findings from study of gel-based platform
TipRanks·11/24/2025 13:45
Gelteq announces ‘positive’ preclinical results for its gel formulation
TipRanks·11/04/2025 00:17
Gelteq Limited Delays 20-F Filing
TipRanks·10/09/2025 12:21
Gelteq enters Product Development, Profit Share Agreement with Melbourne Health
TipRanks·09/12/2025 11:35
Gelteq powers U.S. product launches of Healthy Extracts

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-1.45%

907.99

Biogen Inc

BIIB

-1.64%

220.83

AMGN

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-6.69%

0.1380

Lilly Eli & Co

LLY

-0.88%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

-1.34%

2.210

Johnson & Johnson

JNJ

-1.15%

275.23

Abbvie Inc

ABBV

-1.44%

256.46

Zoetis Inc

ZTS

-0.63%

75.81

GILD

Novo-Nordisk A/S

NVO

-1.92%

46.60

Bristol-Myers Squibb Co

BMY

-1.87%

66.82

ALXN

Pfizer

PFE

-1.25%

28.45

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-1.90%

159.99

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.